News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Cooke_Saskia_A_Amsterdam_web.jpg)
Two different radiation boost strategies reduce local failures in NSCLC
- Author:
- Susan London
The two strategies – one delivering a boost to the whole tumor and the other delivering a boost only to the...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Meduri_Bruno_ITALY_web.jpg)
Long-term APBI cosmetic, toxicity data reported
- Author:
- Susan London
Compared with whole-breast irradiation, APBI delivered with 3D-conformal radiotherapy yielded slightly poorer 5-...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Lambertini_Matteo_Italy_1_web.jpg)
Pregnancy after breast cancer is rockier but doesn’t increase recurrence risk
- Author:
- Susan London
Compared with the general population, breast cancer survivors were less likely to conceive and more likely to...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Kerkmeijer_Linda_Netherlands_web.jpg)
Focal radiation boost nets better outcomes in prostate cancer
- Author:
- Susan London
Adding a boost to the visible tumor on MRI reduced the 5-year risk of biochemical recurrence or death by nearly half, without increasing late...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Cogan_Jacob_NY_web.jpg)
Breast surgery may be a gateway to addictive medication use
- Author:
- Susan London
More than 13% of women who underwent a mastectomy with reconstruction became persistent users of opioids and/or sedative-hypnotic drugs thereafter...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Dummer_Reinhard_Switzerland_web.jpg)
‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma
- Author:
- Susan London
Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Pahalyants_Vartan_MA_web.jpg)
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
- Author:
- Susan London
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
News
Neoadjuvant immunotherapy combo produces high response rate in melanoma
- Author:
- Susan London
Final results of the Neo-C-Nivo trial show a 70% pathologic response rate in patients with high-risk resectable...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Immunotherapy could fill unmet need in leptomeningeal metastases
- Author:
- Susan London
More than a third of patients had a CNS response to systemically administered pembrolizumab, including two patients who had long-lived complete...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Murphy_William_BOSTON_web2.jpg)
Risk factors for severe immune-related AEs identified
- Author:
- Susan London
A nationwide cohort study of more than 14,000 patients finds combination immune checkpoint inhibitor therapy, younger age, and a lung cancer...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/article_teasers/ma_t_martin_ca_web.jpg)
Predictors of upstaging on PSMA PET/CT may help guide its use
- Author:
- Susan London
Patients with high-risk prostate cancer having more positive cores on biopsy or a higher Gleason grade were most likely to experience upstaging...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Kegelman_Timothy_PA_web.jpg)
Lung cancer: Proton beam radiotherapy likely reduces cardiovascular events
- Author:
- Susan London
A retrospective study shows lower rates of transient ischemic attack and MI with proton beam radiotherapy.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Lee_Anna_TX_web.jpg)
Family planning issues loom large for female radiation oncologists
- Author:
- Susan London
Nearly three-quarters of survey respondents said their career choice strongly influenced when they started or planned to start their family.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Michalski_Jeff_MO_web.jpg)
Molecular features of medulloblastoma may help personalize radiotherapy
- Author:
- Susan London
The impact of different radiation-reducing strategies varied across four molecular subgroups.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Jani_Ashesh_GA_web.jpg)
PET guidance for radiation therapy improves prostate cancer outcomes
- Author:
- Susan London
Using PET as well as conventional imaging to guide postprostatectomy radiation therapy reduces the risk of treatment failure.